EUVIMEDEUVIMED entdecken
Crossref

Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function

Yujiro Kidani, Yohko Kitagawa, Masaki Hagiwara iD, Atsunari Kawashima iD, Takayuki Kanazawa, Hisashi Wada, Motohide Uemura, Norio Nonomura, Daisuke Motooka, Shota Nakamura, Naganari Ohkura, Shimon Sakaguchi iD

International Immunology · 09.03.2024 · 36 (4) · 167-182

DOI: 10.1093/intimm/dxad053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, online erschienen am 03.01.2024. Verfasst von Yujiro Kidani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Grant-in-Aid for Specially Promoted Research, Project for Development of Innovative Research on Cancer Therapeutics, Core Research for Evolutional Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Forkhead box P3 (Foxp3)-expressing regulatory T (Treg) cells play essential roles in immune homeostasis but also contribute to establish a favorable environment for tumor growth by suppressing anti-tumor immune responses. It is thus necessary to specifically target tumor-infiltrating Treg cells to minimize effects on immune homeostasis in cancer immunotherapy. However, molecular features that distinguish tumor-infiltrating Treg cells from those in secondary lymphoid organs remain unknown. Here we characterize distinct features of tumor-infiltrating Treg cells by global analyses of the transcriptome and chromatin landscape. They exhibited activated phenotypes with enhanced Foxp3-dependent transcriptional regulation, yet being distinct from activated Treg cells in secondary lymphoid organs. Such differences may be attributed to the extensive clonal expansion of tumor-infiltrating Treg cells. Moreover, we found that TCF7 and LEF1 were specifically downregulated in tumor-infiltrating Treg cells both in mice and humans. These factors and Foxp3 co-occupied Treg suppressive function-related gene loci in secondary lymphoid organ Treg cells, whereas the absence of TCF7 and LEF1 accompanied altered gene expression and chromatin status at these gene loci in tumor-infiltrating Treg cells. Functionally, overexpression of TCF7 and LEF1 in Treg cells inhibited the enhancement of Treg suppressive function upon activation. Our results thus show the downregulation of TCF7 and LEF1 as markers of highly suppressive Treg cells in tumors and suggest that their absence controls the augmentation of Treg suppressive function in tumors. These molecules may be potential targets for novel cancer immunotherapy with minimum effects on immune homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryNeoplasmsHumansAnimalsMiceDown-RegulationForkhead Transcription FactorsChromatinT Cell Transcription Factor 1Lymphoid Enhancer-Binding Factor 1

Stichwörter der Autor:innen

Tregcancer immunotherapyepigenometranscriptional regulation

Substanzen

Forkhead Transcription FactorsChromatinTCF7 protein, humanT Cell Transcription Factor 1LEF1 protein, humanLymphoid Enhancer-Binding Factor 1

Autor:innen und Institutionen

  • Department of Basic Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Biopharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.
  • Department of Urology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Department of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

ORCID-Profile: Masaki Hagiwara, Atsunari Kawashima, Shimon Sakaguchi

Förderung

  • Grant-in-Aid for Specially Promoted Research
  • Project for Development of Innovative Research on Cancer Therapeutics
  • Core Research for Evolutional Science and Technology
  • Leading Advanced Projects for medical innovation
  • Osaka University

Zitieren

APA

Kidani, Y., Kitagawa, Y., Hagiwara, M., Kawashima, A., Kanazawa, T., Wada, H., Uemura, M., Nonomura, N., Motooka, D., Nakamura, S., Ohkura, N., & Sakaguchi, S. (2024). Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function. International Immunology, 36(4), 167-182. https://doi.org/10.1093/intimm/dxad053

Vancouver

Kidani Y, Kitagawa Y, Hagiwara M, Kawashima A, Kanazawa T, Wada H, et al. Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function. International Immunology. 2024;36(4):167-182. doi:10.1093/intimm/dxad053

BibTeX
@article{Kidani2024,
  author = {Kidani, Yujiro and Kitagawa, Yohko and Hagiwara, Masaki and Kawashima, Atsunari and Kanazawa, Takayuki and Wada, Hisashi and Uemura, Motohide and Nonomura, Norio and Motooka, Daisuke and Nakamura, Shota and Ohkura, Naganari and Sakaguchi, Shimon},
  title = {Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function},
  journal = {International Immunology},
  year = {2024},
  volume = {36},
  number = {4},
  pages = {167--182},
  doi = {10.1093/intimm/dxad053}
}
Kostenlos starten →